HCA Healthcare Rides On Acquisitions, Weak Volumes Bother
Zacks Investment Research | Sep 11, 2017 10:53PM ET
HCA Healthcare, Inc. (NYSE:HCA) , one of the most diversified hospital companies in the United States, has achieved growth via a number of acquisitions made over the past many years.
Since its IPO in March 2011 and through the second quarter of 2017, the company spent more than $4.4 billion on acquiring a number of hospitals.
The company is due to acquire two hospitals from Community Health Systems.
These deals have led to an increase in patient volumes and enabled network expansion across several markets. The company’s acquisitions are expected to add scale to its business, positioning it better to weather the regulatory uncertainty in the healthcare sector.
These purchases are backed by HCA Healthcare’s strong balance sheet and consistent increase in cash flows for a number of years. These also provide room for shareholder-friendly capital deployment through buy backs and dividend payouts.
The company’s superior performance is reflective in its share price performance which has gained 5.9% year to date compared with the industry ’s growth of 4.2%.
Nevertheless, the company’s commercial business has recently been facing challenges from declining volumes of admissions. Its international business is also under pressure due to decline in admissions in Middle East and London.
Driven by weakness in business volumes which is expected to persist in the coming quarters, the company narrowed its earnings guidance. It expects adjusted EBITDA of $8.35 billion to $8.5 billion (versus the previous expectation of $8.4 billion to $8.7 billion) and earnings per share of $7.00 to $7.30 for 2017 (versus $7.20-$7.60 expected earlier).
The hospital industry is suffering from low admissions as patients are increasingly choosing to stay away due to high out-of-pocket (which shift the initial costs to patients) costs. Also, a pullback of insurers from public exchanges has increased the uninsured rate which in turn is hurting the company. Given the continued uncertainty about the future of Obamacare, the present scenario is likely to continue in the quarters ahead and drain business volumes.
Other players in the industry like Community Health Systems Inc. (NYSE:CYH) and United Health Services, Inc. (NYSE:UHS) are also victims of political uncertainty.
Universal Health missed second-quarter earnings estimates and cut its 2017 earnings guidance. Community Health incurred a loss in the second quarter and reduced its 2017 earnings guidance.
Zacks Rank & Stock to Consider
Get The News You Want
HCA Healthcare carries a Zacks Rank #3 (Hold). A better-ranked stock in the health care space is Medpace Holdings, Inc. (NASDAQ:MEDP) , sporting a Zacks Rank #1 (Strong Buy). You can see .
Medpace surpassed earnings estimates in three of the last four quarters, with an average positive surprise of 9%.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.